Generic placeholder image

Letters in Drug Design & Discovery

Editor-in-Chief

ISSN (Print): 1570-1808
ISSN (Online): 1875-628X

Review Article

Effects of Dietary Intake and Supplementation of Fatty Acids on Cardiometabolic Disorders in Humans: a Lesson from a Large Number of Meta-Analyses

Author(s): Sho-ichi Yamagishi* and Takanori Matsui

Volume 16, Issue 10, 2019

Page: [1138 - 1145] Pages: 8

DOI: 10.2174/1570180816666181107113148

open access plus

Abstract

Dietary fatty acids have exerted numerous pathophysiological effects in humans. Indeed, monounsaturated fatty acids and ω-3 polyunsaturated fatty acids are generally thought to have favorable cardiometabolic actions via their anti-inflammatory and anti-thrombotic properties, while saturated fatty acids and trans fatty acids are supposed to contribute to the development and progression of atherosclerotic cardiovascular diseases by inducing dyslipidemia and obesity. However, there is much controversy about the effects of dietary intake and supplementation of fatty acids on cardiometabolic disorders. Therefore, in the present study, we limited the scope of this review to metaanalyses (1) of observational studies of dietary intake of fatty acids and (2) of interventional trials with fatty acid supplements to scrutinize the role of fatty acids in various cardiometabolic disorders. We discuss here the clinical effects of fatty acids from dietary intake or supplements on incidence of diabetes, metabolic syndrome, obesity and body weight, cardiovascular diseases and total mortality, and also review the association of fatty acid biomarkers with these cardiometabolic disorders.

Keywords: Cardiovascular disease, diabetes, fatty acids, meta-analysis, obesity, stroke.

Graphical Abstract

[1]
Silva, F.P.; Carla, I.A.; Marcelino, G.; Maiara, L. Cardozo, C.; de C. Freitas, K.; de Cássia A.G.R.; Pereira de Castro, A.; Aragão do Nascimento, V.; Aiko H.P. Fatty Acids Consumption: The role metabolic aspects involved in obesity and its associated disorders. nutrients, 2017. 9(10), 1158.
[http://dx.doi.org/10.3390/nu9101158] [PMID: 29065507]
[2]
Sacks, F.M.; Lichtenstein, A.H.; Wu, J.H.Y.; Appel, L.J.; Creager, M.A.; Kris-Etherton, P.M.; Miller, M.; Rimm, E.B.; Rudel, L.L.; Robinson, J.G.; Stone, N.J.; Van Horn, L.V. Dietary fats and cardiovascular disease: a presidential advisory from the american heart association. Circulation, 2017, 136(3), e1-e23.
[http://dx.doi.org/10.1161/CIR.0000000000000510] [PMID: 28620111]
[3]
Wang, D.D.; Hu, F.B. Dietary fat and risk of cardiovascular disease: recent controversies and advances. Annu. Rev. Nutr., 2017, 37, 423-446.
[http://dx.doi.org/10.1146/annurev-nutr- 071816-064614] [PMID: 28645222]
[4]
Xun, P.; He, K. Fish Consumption and Incidence of Diabetes: meta-analysis of data from 438,000 individuals in 12 independent prospective cohorts with an average 11-year follow-up. Diabetes Care, 2012, 35(4), 930-938.
[http://dx.doi.org/10.2337/dc11-1869] [PMID: 22442398]
[5]
Wallin, A.; Di Giuseppe, D.; Orsini, N.; Patel, P.S.; Forouhi, N.G.; Wolk, A. Fish consumption, dietary long-chain n-3 fatty acids, and risk of type 2 diabetes: systematic review and meta-analysis of prospective studies. Diabetes Care, 2012, 35(4), 918-929.
[http://dx.doi.org/10.2337/dc11-1631] [PMID: 22442397]
[6]
Wu, J.H.; Micha, R.; Imamura, F.; Pan, A.; Biggs, M.L.; Ajaz, O.; Djousse, L.; Hu, F.B.; Mozaffarian, D. Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br. J. Nutr., 2012, 107(Suppl. 2), S214-S227.
[http://dx.doi.org/10.1017/S0007114512001602] [PMID: 22591895]
[7]
Zheng, J.S.; Huang, T.; Yang, J.; Fu, Y.Q.; Li, D. Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: a systematic review and meta-analysis. PLoS One, 2012, 7(9)e44525
[http://dx.doi.org/10.1371/journal.pone.0044525] [PMID: 22984522]
[8]
Zhang, M.; Picard-Deland, E.; Marette, A. Fish and marine omega- 3 polyunsatured Fatty Acid consumption and incidence of type 2 diabetes: a systematic review and meta-analysis. Int. J. Endocrinol., 2013.2013501015
[http://dx.doi.org/10.1155/2013/501015] [PMID: 24089611]
[9]
Zhou, Y.; Tian, C.; Jia, C. Association of fish and n-3 fatty acid intake with the risk of type 2 diabetes: a meta-analysis of prospective studies. Br. J. Nutr., 2012, 108(3), 408-417.
[http://dx.doi.org/10.1017/S0007114512002036] [PMID: 22857650]
[10]
de Souza, R.J.; Mente, A.; Maroleanu, A.; Cozma, A.I.; Ha, V.; Kishibe, T.; Uleryk, E.; Budylowski, P.; Schünemann, H.; Beyene, J.; Anand, S.S. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ, 2015, 351, h3978.
[http://dx.doi.org/10.1136/bmj.h3978] [PMID: 26268692]
[11]
Wu, J.H.Y.; Marklund, M.; Imamura, F.; Tintle, N.; Ardisson Korat, A.V.; de Goede, J.; Zhou, X.; Yang, W.S.; de Oliveira Otto, M.C.; Kröger, J.; Qureshi, W.; Virtanen, J.K.; Bassett, J.K. Frazier- Wood, A.C.; Lankinen, M.; Murphy, R.A.; Rajaobelina, K.; Del Gobbo, L.C.; Forouhi, N.G.; Luben, R.; Khaw, K.T.; Wareham, N.; Kalsbeek, A.; Veenstra, J.; Luo, J.; Hu, F.B.; Lin, H.J.; Siscovick, D.S.; Boeing, H.; Chen, T.A.; Steffen, B.; Steffen, L.M.; Hodge, A.; Eriksdottir, G.; Smith, A.V.; Gudnason, V.; Harris, T.B.; Brouwer, I.A.; Berr, C.; Helmer, C.; Samieri, C.; Laakso, M.; Tsai, M.Y.; Giles, G.G.; Nurmi, T.; Wagenknecht, L.; Schulze, M.B.; Lemaitre, R.N.; Chien, K.L.; Soedamah-Muthu, S.S.; Geleijnse, J.M.; Sun, Q.; Harris, W.S.; Lind, L.; Ärnlöv, J.; Riserus, U.; Micha, R.; Mozaffarian, D. Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies. Lancet Diabetes Endocrinol., 2017, 5(12), 965-974.
[http://dx.doi.org/10.1016/S2213-8587(17)30307-8] [PMID: 29032079]
[12]
Kim, Y.S.; Xun, P.; He, K. Fish consumption, long-chain omega-3 polyunsaturated fatty acid intake and risk of metabolic syndrome: a meta-analysis. Nutrients, 2015, 7(4), 2085-2100.
[http://dx.doi.org/10.3390/nu7042085] [PMID: 25811108]
[13]
Guo, X.F.; Li, X.; Shi, M.; Li, D. n-3 Polyunsaturated Fatty Acids and Metabolic Syndrome Risk: A Meta-Analysis. Nutrients, 2017, 9(7)E703
[http://dx.doi.org/10.3390/nu9070703] [PMID: 28684692]
[14]
Bender, N.; Portmann, M.; Heg, Z.; Hofmann, K.; Zwahlen, M.; Egger, M. Fish or n3-PUFA intake and body composition: a systematic review and meta-analysis. Obes. Rev., 2014, 15(8), 657-665.
[http://dx.doi.org/10.1111/obr.12189] [PMID: 24891155]
[15]
Du, S.; Jin, J.; Fang, W.; Su, Q. Does Fish Oil Have an Anti- Obesity Effect in Overweight/Obese Adults? A Meta-Analysis of Randomized Controlled Trials. PLoS One, 2015, 10(11)e0142652
[http://dx.doi.org/10.1371/journal.pone.0142652] [PMID: 26571503]
[16]
Zhang, Y.Y.; Liu, W.; Zhao, T.Y.; Tian, H.M. Efficacy of Omega- 3 Polyunsaturated Fatty Acids Supplementation in Managing Overweight and Obesity: A Meta-Analysis of Randomized Clinical Trials. J. Nutr. Health Aging, 2017, 21(2), 187-192.
[http://dx.doi.org/10.1007/s12603-016-0755-5] [PMID: 28112774]
[17]
Onakpoya, I.J.; Posadzki, P.P.; Watson, L.K.; Davies, L.A.; Ernst, E. The efficacy of long-term conjugated linoleic acid (CLA) supplementation on body composition in overweight and obese individuals: a systematic review and meta-analysis of randomized clinical trials. Eur. J. Nutr., 2012, 51(2), 127-134.
[http://dx.doi.org/10.1007/s00394-011-0253-9] [PMID: 21990002]
[18]
Whigham, L.D.; Watras, A.C.; Schoeller, D.A. Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am. J. Clin. Nutr., 2007, 85(5), 1203-1211.
[http://dx.doi.org/10.1093/ajcn/85.5.1203] [PMID: 17490954]
[19]
Maki, K.C.; Palacios, O.M.; Bell, M.; Toth, P.P. Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gaps. J. Clin. Lipidol., 2017, 11(5), 1152-1160.e2.
[http://dx.doi.org/10.1016/j.jacl.2017.07.010] [PMID: 28818347]
[20]
Wen, Y.T.; Dai, J.H.; Gao, Q. Effects of Omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Nutr. Metab. Cardiovasc. Dis., 2014, 24(5), 470-475.
[http://dx.doi.org/10.1016/j.numecd.2013.12.004] [PMID: 24472636]
[21]
Kotwal, S.; Jun, M.; Sullivan, D.; Perkovic, V.; Neal, B. Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis. Circ. Cardiovasc. Qual. Outcomes, 2012, 5(6), 808-818.
[http://dx.doi.org/10.1161/CIRCOUTCOMES.112.966168] [PMID: 23110790]
[22]
Kwak, S.M.; Myung, S.K.; Lee, Y.J.; Seo, H.G. Efficacy of omega- 3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch. Intern. Med., 2012, 172(9), 686-694.
[http://dx.doi.org/10.1001/archinternmed.2012.262] [PMID: 22493407]
[23]
Filion, K.B.; El Khoury, F.; Bielinski, M.; Schiller, I.; Dendukuri, N.; Brophy, J.M. Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc. Disord., 2010, 10, 24.
[http://dx.doi.org/10.1186/1471- 2261-10-24] [PMID: 20525225]
[24]
Zhao, Y.T.; Chen, Q.; Sun, Y.X.; Li, X.B.; Zhang, P.; Xu, Y.; Guo, J.H. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Ann. Med., 2009, 41(4), 301-310.
[http://dx.doi.org/10.1080/07853890802698834] [PMID: 19148838]
[25]
Rizos, E.C.; Ntzani, E.E.; Bika, E.; Kostapanos, M.S.; Elisaf, M.S. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA, 2012, 308(10), 1024-1033.
[http://dx.doi.org/10.1001/2012.jama.11374] [PMID: 22968891]
[26]
Chowdhury, R.; Warnakula, S.; Kunutsor, S.; Crowe, F.; Ward, H.A.; Johnson, L.; Franco, O.H.; Butterworth, A.S.; Forouhi, N.G.; Thompson, S.G.; Khaw, K.T.; Mozaffarian, D.; Danesh, J.; Di Angelantonio, E. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and metaanalysis. Ann. Intern. Med., 2014, 160(6), 398-406.
[http://dx.doi.org/10.7326/M13-1788] [PMID: 24723079]
[27]
Chen, Q.; Cheng, L.Q.; Xiao, T.H.; Zhang, Y.X.; Zhu, M.; Zhang, R.; Li, K.; Wang, Y.; Li, Y. Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease: a contemporary meta-analysis of randomized, controlled trials. Cardiovasc. Drugs Ther., 2011, 25(3), 259-265.
[http://dx.doi.org/10.1007/s10557-011-6306-8] [PMID: 21626218]
[28]
Bucher, H.C.; Hengstler, P.; Schindler, C.; Meier, G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am. J. Med., 2002, 112(4), 298-304.
[http://dx.doi.org/10.1016/S0002-9343(01)01114-7] [PMID: 11893369]
[29]
Del Gobbo, L.C.; Imamura, F.; Aslibekyan, S.; Marklund, M.; Virtanen, J.K.; Wennberg, M.; Yakoob, M.Y.; Chiuve, S.E.; Dela Cruz, L.; Frazier-Wood, A.C.; Fretts, A.M.; Guallar, E.; Matsumoto, C.; Prem, K.; Tanaka, T.; Wu, J.H.; Zhou, X.; Helmer, C.; Ingelsson, E.; Yuan, J.M.; Barberger-Gateau, P.; Campos, H.; Chaves, P.H.; Djoussé, L.; Giles, G.G.; Gómez-Aracena, J.; Hodge, A.M.; Hu, F.B.; Jansson, J.H.; Johansson, I.; Khaw, K.T.; Koh, W.P.; Lemaitre, R.N.; Lind, L.; Luben, R.N.; Rimm, E.B.; Risérus, U.; Samieri, C.; Franks, P.W.; Siscovick, D.S.; Stampfer, M.; Steffen, L.M.; Steffen, B.T.; Tsai, M.Y.; van Dam, R.M.; Voutilainen, S.; Willett, W.C.; Woodward, M.; Mozaffarian, D. ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies. JAMA Intern. Med., 2016, 176(8), 1155-1166.
[http://dx.doi.org/10.1001/jamainternmed.2016.2925] [PMID: 27357102]
[30]
Pan, A.; Chen, M.; Chowdhury, R.; Wu, J.H.; Sun, Q.; Campos, H.; Mozaffarian, D.; Hu, F.B. α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am. J. Clin. Nutr., 2012, 96(6), 1262-1273.
[http://dx.doi.org/10.3945/ajcn.112.044040] [PMID: 23076616]
[31]
Whelton, S.P.; He, J.; Whelton, P.K.; Muntner, P. Meta-analysis of observational studies on fish intake and coronary heart disease. Am. J. Cardiol., 2004, 93(9), 1119-1123.
[http://dx.doi.org/10.1016/j.amjcard.2004.01.038] [PMID: 15110203]
[32]
Larsson, S.C.; Orsini, N.; Wolk, A. Long-chain omega-3 polyunsaturated fatty acids and risk of stroke: a meta-analysis. Eur. J. Epidemiol., 2012, 27(12), 895-901.
[http://dx.doi.org/10.1007/s10654- 012-9748-9] [PMID: 23179632]
[33]
Cheng, P.; Huang, W.; Bai, S.; Wu, Y.; Yu, J.; Zhu, X.; Qi, Z.; Shao, W.; Xie, P. BMI affects the relationship between long chain N-3 polyunsaturated fatty acid intake and stroke risk: a Meta-Analysis. Sci. Rep., 2015, 5, 14161.
[http://dx.doi.org/10.1038/srep14161] [PMID: 26369699]
[34]
Yang, B.; Ren, X.L.; Huang, H.; Guo, X.J.; Ma, A.G.; Li, D. Circulating long-chain n-3 polyunsaturated fatty acid and incidence of stroke: a meta-analysis of prospective cohort studies. Oncotarget, 2017, 8(48), 83781-83791.
[http://dx.doi.org/10.18632/oncotarget.19530] [PMID: 29137382]
[35]
Chowdhury, R.; Stevens, S.; Gorman, D.; Pan, A.; Warnakula, S.; Chowdhury, S.; Ward, H.; Johnson, L.; Crowe, F.; Hu, F.B.; Franco, O.H. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. BMJ, 2012. 345e6698.
[http://dx.doi.org/10.1136/bmj.e6698] [PMID: 23112118]
[36]
Wang, C.; Xiong, B.; Huang, J. The Role of Omega-3 Polyunsaturated Fatty Acids in Heart Failure: A Meta-Analysis of Randomised Controlled Trials. Nutrients, 2016, 9(1)E18
[http://dx.doi.org/10.3390/nu9010018] [PMID: 28042816]
[37]
Djoussé, L.; Akinkuolie, A.O.; Wu, J.H.; Ding, E.L.; Gaziano, J.M. Fish consumption, omega-3 fatty acids and risk of heart failure: a meta-analysis. Clin. Nutr, 2012. 31(6), 846-853.
[http://dx.doi.org/10.1016/j.clnu.2012.05.010]] [PMID: 22682084 ]
[38]
Liu, T.; Korantzopoulos, P.; Shehata, M.; Li, G.; Wang, X.; Kaul, S. Prevention of atrial fibrillation with omega-3 fatty acids: a metaanalysis of randomised clinical trials. Heart, 2011, 97(13), 1034-1040.
[http://dx.doi.org/10.1136/hrt.2010.215350] [PMID: 21478384]
[39]
Khawaja, O.; Gaziano, J.M.; Djoussé, L. A meta-analysis of omega- 3 fatty acids and incidence of atrial fibrillation. J. Am. Coll. Nutr., 2012, 31(1), 4-13.
[http://dx.doi.org/10.1080/07315724.2012.10720003] [PMID: 22661621]
[40]
Benedetto, U.; Angeloni, E.; Melina, G.; Danesi, T.H.; Di Bartolomeo, R.; Lechiancole, A.; Refice, S.; Roscitano, A.; Comito, C.; Sinatra, R. n-3 Polyunsaturated fatty acids for the prevention of postoperative atrial fibrillation: a meta-analysis of randomized controlled trials. J. Cardiovasc. Med. (Hagerstown), 2013, 14(2), 104-109.
[http://dx.doi.org/10.2459/JCM.0b013e32834a13c1] [PMID: 21826019]
[41]
Armaganijan, L.; Lopes, R.D.; Healey, J.S.; Piccini, J.P.; Nair, G.M. Morillo, C.A. Do omega-3 fatty acids prevent atrial fibrillation after open heart surgery? A meta-analysis of randomized controlled trials. Clinics (São Paulo), 2011, 66(11), 1923-1928.
[PMID: 22086523]
[42]
Mariani, J.; Doval, H.C.; Nul, D.; Varini, S.; Grancelli, H.; Ferrante, D.; Tognoni, G.; Macchia, A. N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and metaanalysis of randomized controlled trials. J. Am. Heart Assoc., 2013, 2(1)e005033
[http://dx.doi.org/10.1161/JAHA.112.005033] [PMID: 23525440]
[43]
He, Z.; Yang, L.; Tian, J.; Yang, K.; Wu, J.; Yao, Y. Efficacy and safety of omega-3 fatty acids for the prevention of atrial fibrillation: a meta-analysis. Can. J. Cardiol., 2013, 29(2), 196-203.
[http://dx.doi.org/10.1016/j.cjca.2012.03.019] [PMID: 22681963]
[44]
Cao, H.; Wang, X.; Huang, H.; Ying, S.Z.; Gu, Y.W.; Wang, T.; Huang, C.X. Omega-3 fatty acids in the prevention of atrial fibrillation recurrences after cardioversion: a meta-analysis of randomized controlled trials. Intern. Med., 2012, 51(18), 2503-2508.
[http://dx.doi.org/10.2169/internalmedicine.51.7714] [PMID: 22989818]
[45]
Khoueiry, G.; Abi Rafeh, N.; Sullivan, E.; Saiful, F.; Jaffery, Z.; Kenigsberg, D.N.; Krishnan, S.C.; Khanal, S.; Bekheit, S. Kowalski, M. Do omega-3 polyunsaturated fatty acids reduce risk of sudden cardiac death and ventricular arrhythmias? A meta-analysis of randomized trials. Heart Lung, 2013, 42(4), 251-256.
[http://dx.doi.org/10.1016/j.hrtlng.2013.03.006] [PMID: 23714269]
[46]
Campbell, A.; Price, J.; Hiatt, W.R. Omega-3 fatty acids for intermittent claudication. Cochrane Database Syst. Rev., 2013, 7(7)CD003833
[PMID: 23824785]
[47]
Enns, J.E.; Yeganeh, A.; Zarychanski, R.; Abou-Setta, A.M.; Friesen, C.; Zahradka, P.; Taylor, C.G. The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis. BMC Cardiovasc. Disord., 2014, 14, 70.
[http://dx.doi.org/10.1186/1471-2261-14-70] [PMID: 24885361]
[48]
de Goede, J.; Verschuren, W.M.M.; Boer, J.M.A.; Verberne, L.D.; Kromhout, D.; Geleijnse, J.M. N-6 and N-3 fatty acid cholesteryl esters in relation to fatal CHD in a Dutch adult population: a nested case-control study and meta-analysis. PLoS One, 2013, 8(5)e59408
[http://dx.doi.org/10.1371/journal.pone.0059408] [PMID: 23741290]
[49]
Farvid, M.S.; Ding, M.; Pan, A.; Sun, Q.; Chiuve, S.E.; Steffen, L.M.; Willett, W.C.; Hu, F.B. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation, 2014, 130(18), 1568-1578.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.114.010236] [PMID: 25161045]
[50]
Mozaffarian, D.; Micha, R.; Wallace, S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med., 2010, 7(3)e1000252
[http://dx.doi.org/10.1371/journal.pmed.1000252] [PMID: 20351774]
[51]
Ramsden, C.E.; Zamora, D.; Leelarthaepin, B.; Majchrzak-Hong, S.F.; Faurot, K.R.; Suchindran, C.M.; Ringel, A.; Davis, J.M.; Hibbeln, J.R. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ, 2013. 346e8707
[http://dx.doi.org/10.1136/bmj.e8707] [PMID: 23386268]
[52]
Ramsden, C.E.; Hibbeln, J.R.; Majchrzak, S.F.; Davis, J.M. n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br. J. Nutr., 2010, 104(11), 1586-1600.
[http://dx.doi.org/10.1017/S0007114510004010] [PMID: 21118617]
[53]
Siri-Tarino, P.W.; Sun, Q.; Hu, F.B.; Krauss, R.M. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am. J. Clin. Nutr., 2010, 91(3), 535-546.
[http://dx.doi.org/10.3945/ajcn.2009.27725] [PMID: 20071648]
[54]
Cheng, P.; Wang, J.; Shao, W.; Liu, M.; Zhang, H. Can dietary saturated fat be beneficial in prevention of stroke risk? A metaanalysis. Neurol. Sci., 2016, 37(7), 1089-1098.
[http://dx.doi.org/10.1007/s10072-016-2548-3] [PMID: 26979840]
[55]
Bendsen, N.T.; Christensen, R.; Bartels, E.M.; Astrup, A. Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies. Eur. J. Clin. Nutr., 2011, 65(7), 773-783.
[http://dx.doi.org/10.1038/ejcn.2011.34] [PMID: 21427742]
[56]
Schwingshackl, L.; Strasser, B.; Hoffmann, G. Effects of monounsaturated fatty acids on cardiovascular risk factors: a systematic review and meta-analysis. Ann. Nutr. Metab., 2011, 59(2-4), 176-186.
[http://dx.doi.org/10.1159/000334071] [PMID: 22142965]
[57]
Jakobsen, M.U.; O’Reilly, E.J.; Heitmann, B.L.; Pereira, M.A.; Bälter, K.; Fraser, G.E.; Goldbourt, U.; Hallmans, G.; Knekt, P.; Liu, S.; Pietinen, P.; Spiegelman, D.; Stevens, J.; Virtamo, J.; Willett, W.C.; Ascherio, A. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am. J. Clin. Nutr., 2009, 89(5), 1425-1432.
[http://dx.doi.org/10.3945/ajcn.2008.27124] [PMID: 19211817]
[58]
Cheng, P.; Wang, J.; Shao, W. Monounsaturated fatty acid intake and stroke risk: a meta-analysis of prospective studies. J. Stroke Cerebrovasc. Dis., 2016, 25(6), 1326-1334.
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2016.02.017] [PMID: 26987490]

© 2024 Bentham Science Publishers | Privacy Policy